Spots Global Cancer Trial Database for metastatic endometrioid adenocarcinoma

Every month we try and update this database with for metastatic endometrioid adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer	NCT02728258	Endometrial End... Endometrial Mix... Endometrial Ser... Endometrial Und... Metastatic Endo... Recurrent Uteri...	Copanlisib Laboratory Biom...	18 Years -	NRG Oncology
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer	NCT01935934	Endometrial Ade... Endometrial Cle... Endometrial Mix... Endometrial Ser... Metastatic Endo... Recurrent Uteri... Stage IV Uterin... Stage IVA Uteri... Stage IVB Uteri... Uterine Corpus ...	Cabozantinib S-... Laboratory Biom... Pharmacological...	18 Years -	National Cancer Institute (NCI)
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer	NCT01935934	Endometrial Ade... Endometrial Cle... Endometrial Mix... Endometrial Ser... Metastatic Endo... Recurrent Uteri... Stage IV Uterin... Stage IVA Uteri... Stage IVB Uteri... Uterine Corpus ...	Cabozantinib S-... Laboratory Biom... Pharmacological...	18 Years -	National Cancer Institute (NCI)
Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer	NCT02728258	Endometrial End... Endometrial Mix... Endometrial Ser... Endometrial Und... Metastatic Endo... Recurrent Uteri...	Copanlisib Laboratory Biom...	18 Years -	NRG Oncology
Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer	NCT04498520	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Hormone Recepto... Locally Advance... Metastatic Brea... Metastatic Endo... Metastatic Fall... Metastatic HER2... Metastatic Mali... Metastatic Ovar... Metastatic Prim... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Refractory Brea... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IV Uterin... Stage IVA Fallo... Stage IVA Ovari... Stage IVA Prima... Stage IVA Uteri... Stage IVB Fallo... Stage IVB Ovari... Stage IVB Prima... Stage IVB Uteri...	Abexinostat Tos... Fulvestrant Palbociclib	18 Years -	University of California, San Francisco
Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer	NCT04498520	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Hormone Recepto... Locally Advance... Metastatic Brea... Metastatic Endo... Metastatic Fall... Metastatic HER2... Metastatic Mali... Metastatic Ovar... Metastatic Prim... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Refractory Brea... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IV Uterin... Stage IVA Fallo... Stage IVA Ovari... Stage IVA Prima... Stage IVA Uteri... Stage IVB Fallo... Stage IVB Ovari... Stage IVB Prima... Stage IVB Uteri...	Abexinostat Tos... Fulvestrant Palbociclib	18 Years -	University of California, San Francisco

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: